Hilton Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-106
Closed -$25K 177
2019
Q3
$25K Hold
106
﹤0.01% 238
2019
Q2
$30K Sell
106
-258
-71% -$70.5K ﹤0.01% 256
2019
Q1
$104K Buy
364
+117
+47% +$33.8K 0.01% 155
2018
Q4
$65K Buy
+247
New +$67.9K 0.01% 162

Other funds holding ELV

Hilton Capital Management's ELV Position: Q4 2019 in Review

Hilton Capital Management sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 106 shares — an estimated $25K sold.

Hilton Capital Management first reported a position in ELV in Q4 2018 and held it in 4 quarters. The position peaked at $104K in Q1 2019. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Hilton Capital Management reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
  • Hilton Capital Management sold 106 Elevance Health shares in Q4 2019, an estimated $25K.
  • Hilton Capital Management first reported a position in Elevance Health in Q4 2018 and held it in 4 quarters.
  • Hilton Capital Management's Elevance Health position peaked at $104K in Q1 2019.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Hilton Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.